文献速递肝病消化道肿瘤与早癌

邮寄外展策略促进肝细胞癌监测的多中心随机临床试验

Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-12-10

这项多中心实用随机临床试验在3个卫生系统的肝硬化患者中比较邮寄监测超声外展(n=1436)与常规就诊监测(n=1436)。外展组半年监测率显著高于常规组(35.1% vs 21.9%),无监测率更低(29.8% vs 43.5%),监测覆盖时间比例更高(41.3% vs 31.0%)。

要点

  • 邮寄外展组半年肝细胞癌监测率35.1%,常规组21.9%(P < .001)。
  • 外展组无监测率29.8%,常规组43.5%(P < .001)。
  • 干预效果在退伍军人事务和 safety net 卫生系统显著,在三级转诊中心不显著。

核心结论

  • 在肝硬化患者中,邮寄外展较常规护理显著提高半年肝细胞癌监测率,且大多数预设亚组干预效果一致。
  • 持续随访正在进行,以确定监测增加是否转化为早期肝细胞癌检测和治愈性治疗接受等下游结局改善。

研究设计与样本

  • 多中心实用随机临床试验,比较邮寄监测超声外展(n=1436)与常规就诊监测(n=1436)。
  • 纳入3个卫生系统(三级转诊中心、safety net 卫生系统、退伍军人事务医疗中心)的肝硬化患者,时间为2018年4月至2019年12月。
  • 所有患者纳入意向筛查分析。

主要发现

  • 外展组半年监测率35.1%,常规组21.9%,差异显著(P < .001)。
  • 外展组无监测率29.8%,常规组43.5%,差异显著(P < .001)。
  • 外展组监测覆盖时间比例41.3%,常规组31.0%,差异显著(P < .001)。
  • 干预在退伍军人事务和 safety net 卫生系统显著提高半年监测率,在三级转诊中心未显著提高。

关键数值与推荐

  • 主要结局为12个月内符合指南的半年肝细胞癌监测。
  • 次要结局为监测覆盖的时间比例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effectiveness of hepatocellular carcinoma (HCC) surveillance is mitigated by underuse in clinical practice, highlighting a need for interventions. We evaluated the effectiveness of mailed HCC surveillance outreach to promote HCC surveillance in patients with cirrhosis. METHODS: We conducted a multicenter pragmatic randomized clinical trial comparing mailed outreach for surveillance ultrasound (n = 1436) and usual care with visit-based surveillance (n = 1436) among patients with cirrhosis at 3 health systems (tertiary care referral center, safety net health system, and Veterans Affairs medical center) from April 2018 to December 2019. The primary outcome of this interim analysis was guideline concordant semiannual HCC surveillance over a 12-month period and a secondary outcome was proportion time covered by surveillance. All patients were included in intention-to-screen analyses. RESULTS: Compared with usual care, the outreach arm had significantly higher semiannual surveillance (35.1% vs 21.9%) and lower no-surveillance (29.8% vs 43.5%) (P < .001), resulting in significant increases in the proportion of time covered by surveillance (41.3% vs 31.0%; P < .001). The intervention increased HCC surveillance across most predefined subgroups; however, there were site-level differences in the intervention effect, with significant increases in semiannual surveillance at the Veterans Affairs and safety net health systems but not at the tertiary care referral center. CONCLUSIONS: Mailed outreach significantly increased semiannual HCC surveillance vs usual care in patients with cirrhosis, with a consistent intervention effect across most examined subgroups. Continued follow-up is ongoing to determine if these increases in surveillance translate into improved downstream outcomes includi.ng early HCC detection and curative treatment receipt. (ClinicalTrials.gov, Numbers: NCT02582918 and NCT03756051).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Singal AG, Reddy S, Radadiya Aka Patel H, et al. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2021. PMID: 34902568. doi:10.1016/j.cgh.2021.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。